NUVA
Price:
$39.75
Market Cap:
$2.08B
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal ...[Read more]
Industry
Medical - Devices
IPO Date
2004-05-13
Stock Exchange
NASDAQ
Ticker
NUVA
According to NuVasive, Inc.’s latest financial reports and current stock price. The company's current ROE is 4.86%. This represents a change of 499.10% compared to the average of 0.81% of the last 4 quarters.
The mean historical ROE of NuVasive, Inc. over the last ten years is 2.52%. The current 4.86% ROE has changed 92.65% with respect to the historical average. Over the past ten years (40 quarters), NUVA's ROE was at its highest in in the March 2015 quarter at 4.82%. The ROE was at its lowest in in the June 2020 quarter at -5.59%.
Average
2.52%
Median
3.07%
Minimum
-8.06%
Maximum
10.44%
Discovering the peaks and valleys of NuVasive, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 376.67%
Maximum Annual ROE = 10.44%
Minimum Annual Increase = -465.18%
Minimum Annual ROE = -8.06%
Year | ROE | Change |
---|---|---|
2022 | 4.65% | -157.70% |
2021 | -8.06% | 99.33% |
2020 | -4.04% | -156.72% |
2019 | 7.13% | 376.67% |
2018 | 1.50% | -85.67% |
2017 | 10.44% | 95.25% |
2016 | 5.35% | -43.97% |
2015 | 9.54% | -465.18% |
2014 | -2.61% | -296.96% |
2013 | 1.33% | 126.78% |
The current ROE of NuVasive, Inc. (NUVA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.48%
5-year avg
0.23%
10-year avg
2.52%
NuVasive, Inc.’s ROE is greater than Glaukos Corporation (-26.64%), less than CONMED Corporation (15.04%), less than LivaNova PLC (1.88%), less than Masimo Corporation (5.65%), greater than OrthoPediatrics Corp. (-7.64%), greater than Pulmonx Corporation (-53.88%), greater than SI-BONE, Inc. (-22.51%), greater than Orthofix Medical Inc. (-21.25%), greater than Heska Corporation (-4.29%), less than Bruker Corporation (19.04%), greater than Paragon 28, Inc. (-38.77%), less than Avanos Medical, Inc. (1.28%), greater than Nevro Corp. (-24.76%), less than Integer Holdings Corporation (7.30%),
Company | ROE | Market cap |
---|---|---|
-26.64% | $7.94B | |
15.04% | $2.31B | |
1.88% | $2.79B | |
5.65% | $9.26B | |
-7.64% | $637.85M | |
-53.88% | $268.12M | |
-22.51% | $526.74M | |
-21.25% | $722.63M | |
-4.29% | $1.31B | |
19.04% | $8.65B | |
-38.77% | $838.76M | |
1.28% | $854.80M | |
-24.76% | $169.37M | |
7.30% | $4.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuVasive, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NuVasive, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NuVasive, Inc.'s ROE?
How is the ROE calculated for NuVasive, Inc. (NUVA)?
What is the highest ROE for NuVasive, Inc. (NUVA)?
What is the 3-year average ROE for NuVasive, Inc. (NUVA)?
What is the 5-year average ROE for NuVasive, Inc. (NUVA)?
How does the current ROE for NuVasive, Inc. (NUVA) compare to its historical average?